These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 17577060)

  • 1. Antimicrobial activity of lacticin 3,147 against clinical Clostridium difficile strains.
    Rea MC; Clayton E; O'Connor PM; Shanahan F; Kiely B; Ross RP; Hill C
    J Med Microbiol; 2007 Jul; 56(Pt 7):940-946. PubMed ID: 17577060
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro inhibition of Clostridium difficile and Clostridium perfringens by commercial probiotic strains.
    Schoster A; Kokotovic B; Permin A; Pedersen PD; Dal Bello F; Guardabassi L
    Anaerobe; 2013 Apr; 20():36-41. PubMed ID: 23471038
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prebiotic preferences of human lactobacilli strains in co-culture with bifidobacteria and antimicrobial activity against Clostridium difficile.
    Ambalam P; Kondepudi KK; Balusupati P; Nilsson I; Wadström T; Ljungh Å
    J Appl Microbiol; 2015 Dec; 119(6):1672-82. PubMed ID: 26381324
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of NVB302 versus vancomycin activity in an in vitro human gut model of Clostridium difficile infection.
    Crowther GS; Baines SD; Todhunter SL; Freeman J; Chilton CH; Wilcox MH
    J Antimicrob Chemother; 2013 Jan; 68(1):168-76. PubMed ID: 22966180
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nisin is an effective inhibitor of Clostridium difficile vegetative cells and spore germination.
    Lay CL; Dridi L; Bergeron MG; Ouellette M; Fliss IL
    J Med Microbiol; 2016 Feb; 65(2):169-175. PubMed ID: 26555543
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in predominant bacterial populations in human faeces with age and with Clostridium difficile infection.
    Hopkins MJ; Macfarlane GT
    J Med Microbiol; 2002 May; 51(5):448-454. PubMed ID: 11990498
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of lactulose on short-chain fatty acids and lactate production and on the growth of faecal flora, with special reference to Clostridium difficile.
    Ito Y; Moriwaki H; Muto Y; Kato N; Watanabe K; Ueno K
    J Med Microbiol; 1997 Jan; 46(1):80-4. PubMed ID: 9003750
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Antimicrobial activity of oral quinolones against clinical isolates of Bifidobacterium group and Clostridium difficile].
    Kimura M; Yamagishi Y; Terada M; Ohki E; Tanaka K; Watanabe K; Mikamo H
    Jpn J Antibiot; 2010 Apr; 63(2):171-7. PubMed ID: 20919497
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New selective medium for isolating Clostridium difficile from faeces.
    Aspinall ST; Hutchinson DN
    J Clin Pathol; 1992 Sep; 45(9):812-4. PubMed ID: 1401214
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antimicrobial susceptibilities of canine Clostridium difficile and Clostridium perfringens isolates to commonly utilized antimicrobial drugs.
    Marks SL; Kather EJ
    Vet Microbiol; 2003 Jun; 94(1):39-45. PubMed ID: 12742714
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clostridium difficile: prevalence in horses and environment, and antimicrobial susceptibility.
    Båverud V; Gustafsson A; Franklin A; Aspán A; Gunnarsson A
    Equine Vet J; 2003 Jul; 35(5):465-71. PubMed ID: 12875324
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro inhibition of Clostridium difficile by commercial probiotics: A microcalorimetric study.
    Fredua-Agyeman M; Stapleton P; Basit AW; Beezer AE; Gaisford S
    Int J Pharm; 2017 Jan; 517(1-2):96-103. PubMed ID: 27923699
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fate and efficacy of lacticin 3147-producing Lactococcus lactis in the mammalian gastrointestinal tract.
    Dobson A; Crispie F; Rea MC; O'Sullivan O; Casey PG; Lawlor PG; Cotter PD; Ross P; Gardiner GE; Hill C
    FEMS Microbiol Ecol; 2011 Jun; 76(3):602-14. PubMed ID: 21314706
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Time-kill kinetics of cadazolid and comparator antibacterial agents against different ribotypes of Clostridium difficile.
    Skinner K; Birchall S; Corbett D; Thommes P; Locher HH
    J Med Microbiol; 2018 Sep; 67(9):1402-1409. PubMed ID: 30052178
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antimicrobial susceptibility of Clostridium difficile isolated from food animals on farms.
    Thitaram SN; Frank JF; Siragusa GR; Bailey JS; Dargatz DA; Lombard JE; Haley CA; Lyon SA; Fedorka-Cray PJ
    Int J Food Microbiol; 2016 Jun; 227():1-5. PubMed ID: 27043382
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An In Vitro Model of the Human Colon: Studies of Intestinal Biofilms and Clostridium difficile Infection.
    Crowther GS; Wilcox MH; Chilton CH
    Methods Mol Biol; 2016; 1476():223-34. PubMed ID: 27507345
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro activity of cadazolid against clinically relevant Clostridium difficile isolates and in an in vitro gut model of C. difficile infection.
    Chilton CH; Crowther GS; Baines SD; Todhunter SL; Freeman J; Locher HH; Athanasiou A; Wilcox MH
    J Antimicrob Chemother; 2014 Mar; 69(3):697-705. PubMed ID: 24128668
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A combination of the probiotic and prebiotic product can prevent the germination of Clostridium difficile spores and infection.
    Rätsep M; Kõljalg S; Sepp E; Smidt I; Truusalu K; Songisepp E; Stsepetova J; Naaber P; Mikelsaar RH; Mikelsaar M
    Anaerobe; 2017 Oct; 47():94-103. PubMed ID: 28465256
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective growth-inhibitory effect of 8-hydroxyquinoline towards Clostridium difficile and Bifidobacterium longum subsp. longum in co-culture analysed by flow cytometry.
    Novakova J; Džunková M; Musilova S; Vlkova E; Kokoska L; Moya A; D'Auria G
    J Med Microbiol; 2014 Dec; 63(Pt 12):1663-1669. PubMed ID: 25298160
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rapid change of fecal microbiome and disappearance of Clostridium difficile in a colonized infant after transition from breast milk to cow milk.
    Davis MY; Zhang H; Brannan LE; Carman RJ; Boone JH
    Microbiome; 2016 Oct; 4(1):53. PubMed ID: 27717398
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.